| Role |
Title and funding source |
Duration |
| Federal |
| Program Director / Principal Investigator |
Immunogenicity of a Xenogeneic Bioartificial Liver.
Funded by the National Institute of Diabetes and Digestive and Kidney Diseases. |
April 1999 to March 2005 |
| Program Director / Principal Investigator |
Xenogenic Bioartificial Liver.
Funded by the National Institute of Diabetes and Digestive and Kidney Diseases. |
July 2006 to June 2010 |
| Foundation |
| Principal Investigator |
Roche Laboratories Presidential Travel Award.
Funded by American Society of Transplant Surgeons. |
July 2000 to June 2001 |
| Co-investigator |
Investigation of Tissue Level Expression and Secretion of Matrix Metalloproteinase 2 and 9 (Gelatinases) in a Porcine Polytetrafluoroethylene Graft Model of Venous Stenoses.
Funded by Cardiovascular and Interventional Radiology Research and Educational Foundation. |
October 2000 to November 2006 |
| Industry |
| Principal Investigator |
A Phase II/III, Multicenter, Randomized, Controlled, Parallel Group Study of the HepatAssist Liver Assist System (LAS) Compared to Standard ICV Care in Patients with Acute Hepatic Failure and Hepatic Encephalopathy.
Funded by CIRCE Biomedical. |
April 1997 to July 2000 |
| Principal Investigator |
An Industry-Sponsored Phase II/III Clinical Study of the HepatAssist®Liver Assist System for the Treatment of Acute Liver Failure.
Funded by Circe Biomedical and Mayo Clinic. |
January 1998 to January 2001 |
| Principal Investigator |
Immune Response to a Xenogeneic Bioartificial Liver.
Funded by ASTS Roche Presidential Travel Award. |
January 2000 |
| Principal Investigator |
A Pilot Study of Synthetic ECM/Basement Membrane on Gene Expression and Biochemical Function of Rat Hepatocytes in Vitro.
Funded by Donaldson Company. |
October 2005 to February 2008 |
| Principal Investigator |
Hepatic Tissue Research Registry: Brief 1.
Funded by Asterand. |
January 2007 to December 2008 |
| Co-investigator |
Study of the Antiviral Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus infection.
Funded by Bristol-Myers Squibb Pharmaceutical. |
September 2007 to August 2010 |
| Co-investigator |
A Phase II Randomized, Multicenter, Active Comparator-Controlled Trial to Evaluate the Safety and Efficacy of Coadministration of CP-690,550 and Mycophenolate Mofetil / Mycophenolate Sodium in De Novo Kidney Allograft Recipients.
Funded by Pfizer Inc. |
October 2007 to September 2009 |
| Co-investigator |
A Phase II, Open-Label, Multicenter, Prospective, Conversion Study in Stable Liver Transplant Patients to Compare the Pharmacokinetics of LCP-Tacro Tablets Once-a-Day to Prograf Capsules Twice-a-Day.
Funded by Life Cycle. |
January 2008 to December 2008 |
| Co-investigator |
A Phase II, Open-Label, Multicenter, Randomized Trial to Demonstrate the Pharmacokinetics of LCP-Tacro Tablets Once Daily and Prograf Capsules Twice Daily in Adult De Novo Liver Transplant Patients.
Funded by Life Cycle. (LCP-Tacro 2018) |
December 2008 to November 2010 |
| Program Director / Principal Investigator |
Hepatopig: A Model for Liver Cirrhosis, Hepatocellular Carcinoma and for Repopulation of the Liver with Transplanted Human Hepatocytes.
Funded by Yecuris Inc. |
April 2010 to March 2011 |
| Mayo Clinic |
| Principal Investigator |
Noninvasive Measurement of Brain Glutamine by MR Spectroscopy During Acute Hepatic Failure.
Funded by Mayo Foundation Scholarship. |
January 1996 to January 1997 |
| Principal Investigator |
Glycine Cytoprotection of Hepatocytes in a Bioartificial Liver.
Funded by Mayo Clinic. |
January 1997 to January 1998 |
| Principal Investigator |
Cell Processing Budget for Circe BAL Study.
Funded by Mayo Clinic. |
October 1997 to September 2000 |
| Principal Investigator |
Apoptosis and Necrosis of Hepatocytes in a Bioartificial Liver.
Funded by Mayo Clinic. |
January 1998 to January 2000 |
| Principal Investigator |
An Improved Bioartificial Liver for Extended Therapy.
Funded by a Discovery Translation Award from Mayo Clinic. |
July 2007 to June 2009 |
| Program Director / Principal Investigator |
Feasibility Study of Fetal Transplantation and Immune Tolerization in Pigs.
Funded by the Small Grants Program at Mayo Clinic. |
August 2009 to August 2010 |
| Program Director / Principal Investigator |
Role of Toll-Like Receptor 4 in the Systemic Inflammatory Response Syndrome of Acute Liver Failure.
Funded by the Small Grants Programs at Mayo Clinic. |
September 2010 to August 2011 |